Just so we are clear. A tthis point all we have is an A2 market announcement on wha twas said. We do not have an announcement by the FDA. And the FDA is pretty good at its daily news updates. Maybe that is simply a function of time zones.
However what is a reality is that there was a sever shortage of IF in the USA. This has been mitigated to some extent by foreign imports and internal US manufacturing is rampling up again. Along with interstate product transfers within WIC's
We can argue semantics around the words "deferred" or "rejected" but bottom line to me seems to be that A2 is no longer in the running.
Lets face it. This created a bit of excitement and no doubt day traders have done very nicely out of this over the past few months. In the absence of any other news time to just sit back, take a breath, relax and wait for the year end announcement details.
A2M Price at posting:
$4.70 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)